GFM
RMD icon

GF Fund Management’s ResMed RMD Stock Holding History

GF Fund Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784K Buy
4,021
+42
+1% +$8.71K 0.01% 196
2026
Q1 		$893K Hold
3,979
– – 0.01% 196
2025
Q4 		$958K Sell
3,979
-73
-2% -$18.7K 0.02% 198
2025
Q3 		$1.11M Buy
4,052
+446
+12% +$122K 0.02% 193
2025
Q2 		$930K Sell
3,606
-26
-0.7% -$6.2K 0.02% 214
2025
Q1 		$813K Hold
3,632
– – 0.02% 216
2024
Q4 		$831K Buy
+3,632
New +$875K 0.02% 206

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GF Fund Management's RMD Position: Q2 2026 in Review

GF Fund Management increased its ResMed (RMD) stake by 1.1% in Q2 2026, buying an estimated $8.71K and bringing the position to 4,021 shares worth $784K. The position accounts for 0.01% of the portfolio, ranked #196.

GF Fund Management first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.11M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • GF Fund Management held 4,021 shares of ResMed worth $784K as of Q2 2026.
  • GF Fund Management bought 42 ResMed shares in Q2 2026, an estimated $8.71K.
  • ResMed made up 0.01% of GF Fund Management's portfolio in Q2 2026, its #196 holding.
  • GF Fund Management first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's ResMed position peaked at $1.11M in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.